Jones Financial Companies
LEGN icon

Jones Financial Companies’s Legend Biotech LEGN Stock Holding History

Jones Financial Companies’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$258 Sell
9
-9
-50% -$243 ﹤0.01% 4835
2026
Q1 		$302 Hold
18
– – ﹤0.01% 4558
2025
Q4 		$391 Buy
18
+7
+64% +$201 ﹤0.01% 4196
2025
Q3 		$367 Buy
11
+9
+450% +$332 ﹤0.01% 4078
2025
Q2 		$69 Buy
+2
New +$65 ﹤0.01% 3962

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Jones Financial Companies's LEGN Position: Q2 2026 in Review

Jones Financial Companies reduced its Legend Biotech (LEGN) stake by 50% in Q2 2026, selling an estimated $243 and leaving 9 shares worth $258. The position accounts for ﹤0.01% of the portfolio, ranked #4835.

Jones Financial Companies first reported a position in LEGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $391 in Q4 2025. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Jones Financial Companies held 9 shares of Legend Biotech worth $258 as of Q2 2026.
  • Jones Financial Companies sold 9 Legend Biotech shares in Q2 2026, an estimated $243.
  • Legend Biotech made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4835 holding.
  • Jones Financial Companies first reported a position in Legend Biotech in Q2 2025 and has held it in 5 quarters since.
  • Jones Financial Companies's Legend Biotech position peaked at $391 in Q4 2025.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.